Cargando…

The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice

The incidence of infections caused by the H7N9 subtype of the influenza virus has expanded rapidly in China in recent decades, generating massive economic loss and posing a significant threat to public health. In the absence of specialized antiviral treatments or long-term effective preventative vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jianru, Hu, Bing, Song, Qiqi, Wang, Ruijuan, Zhang, Xiangfei, Yu, Yaqi, Wang, Jian-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582854/ https://www.ncbi.nlm.nih.gov/pubmed/36274725 http://dx.doi.org/10.3389/fmicb.2022.1003714

Ejemplares similares

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
por: Goksøyr, Louise, et al.
Publicado: (2022)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice
por: Qin, Jianru, et al.
Publicado: (2018)

A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Protective Immune Responses in M. tuberculosis H37Ra Infected Mice
por: Wang, Juan, et al.
Publicado: (2023)

Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platform
por: Panasiuk, Mirosława, et al.
Publicado: (2023)

Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice
por: Liu, Qiliang, et al.
Publicado: (2014)

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
por: Crevar, Corey J, et al.
Publicado: (2008)

Spatio-temporal spread and evolution of influenza A (H7N9) viruses
por: Shi, Zhibin, et al.
Publicado: (2022)

Genome-Wide Search for Competing Endogenous RNAs Responsible for the Effects Induced by Ebola Virus Replication and Transcription Using a trVLP System
por: Wang, Zhong-Yi, et al.
Publicado: (2017)

Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
por: Yu, Dong-Shan, et al.
Publicado: (2018)

Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
por: Yu, Dong-Shan, et al.
Publicado: (2020)

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
por: Rolih, Valeria, et al.
Publicado: (2020)

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
por: Marini, Arianna, et al.
Publicado: (2019)

Response to HIV-1 gp160-carrying recombinant virus HSV-1 and HIV-1 VLP combined vaccine in BALB/c mice
por: Zhang, Beibei, et al.
Publicado: (2023)

A Cross-Reactive Monoclonal Antibody Against Neuraminidases of Both H9N2 and H3N2 Influenza Viruses Shows Protection in Mice Challenging Models
por: Wang, Fei, et al.
Publicado: (2021)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems
por: Thompson, Christine M, et al.
Publicado: (2015)

Targeted Enzymatic VLP‐Nanoreactors with β‐Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease
por: Chauhan, Kanchan, et al.
Publicado: (2022)

Pandemic (H1N1) 2009 Influenza Virus Infection in A Survivor Who Has Recovered from Severe H7N9 Virus Infection, China
por: Chen, Shan-Hui, et al.
Publicado: (2016)

A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection
por: Yang, Limin, et al.
Publicado: (2022)

Comparative Pathogenicity and Transmissibility of Pandemic H1N1, Avian H5N1, and Human H7N9 Influenza Viruses in Tree Shrews
por: Xu, Shuai, et al.
Publicado: (2019)

Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses
por: Sun, Zhihao, et al.
Publicado: (2018)

Severely Heat Injured Survivors of E. coli O157:H7 ATCC 43888 Display Variable and Heterogeneous Stress Resistance Behavior
por: Gayán, Elisa, et al.
Publicado: (2016)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

Comparison of H7N9 and H9N2 influenza infections in mouse model unravels the importance of early innate immune response in host protection
por: Zhu, Cuisong, et al.
Publicado: (2022)

An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
por: Setyo Utomo, Doddy Irawan, et al.
Publicado: (2023)

A replication-deficient H9N2 influenza virus carrying H5 hemagglutinin conferred protection against H9N2 and H5N1 influenza viruses in mice
por: Ren, Weigang, et al.
Publicado: (2022)

An overview of the characteristics of the novel avian influenza A H7N9 virus in humans
por: Tan, Kei-Xian, et al.
Publicado: (2015)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Internal Gene Cassette From a Human-Origin H7N9 Influenza Virus Promotes the Pathogenicity of H9N2 Avian Influenza Virus in Mice
por: Zhang, Miaomiao, et al.
Publicado: (2020)

High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults
por: Qin, Ling, et al.
Publicado: (2018)

Genetic characterization and pathogenicity of H7N9 highly pathogenic avian influenza viruses isolated from South China in 2017
por: Zhao, Bingbing, et al.
Publicado: (2023)

A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection
por: Akahata, Wataru, et al.
Publicado: (2010)

Enhanced Potency of a Broad H7N9-Neutralizing Antibody HNIgGA6 Through Structure-Based Design
por: Chen, Cong, et al.
Publicado: (2020)

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2023)

Correction: Wang et al. A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice. Vaccines 2023, 11, 941
por: Wang, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rgkm9cpcq1vte6295quf1tpdo